A new study led by NYU Langone Health researchers has found that cancer cells are better able to resist treatments when they ...

Scientists want to know what causes B cells — which direct T cells to attack cancer — to malfunction and how they can be ...

Cancer cells frequently develop the ability to expel anticancer drugs before they can work—a phenomenon called multidrug resistance (MDR)—which is one of the leading reasons why chemotherapy fails in ...

Researchers at a university are exploring how endometriosis could influence the development of ovarian cancer and lead to ...

When the body encounters infection or cancer, cytotoxic T lymphocytes attach to the affected cell and form the immune synapse ...

Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it ...

A new study led by NYU Langone Health researchers found that cancer cells are better able to resist treatments when they have ...

A new strategy to strengthen the body’s natural immune defenses against cancer is showing early promise, particularly for patients with limited treatment options.

A new kind of CRISPR that destroys cells rather than gene editing them has shown potential for killing sick cells while leaving healthy cells untouched. The technology has largely been tested in cells ...

The first clinical trial to test the tumour-fighting power of a stem-cell-like class of long-lived immune cells suggests that ...

Scientists from the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute have deciphered a key mechanism ...